2024 Employee Benefit Cost Drivers:
1. Broader Economics: "Healthcare providers continue to experience significant financial challenges driven by decreases in revenue, intense staffing shortages, and rising expenses for supplies, equipment and drugs...While broader inflation markers have been trending downward over the past several months, medical inflation tends to lag by as much as 12 months."
2. Prescription Drugs + Emerging Gene & Cellular Therapies: "Specialty drugs are typically complex, high-cost and often used to treat rare or chronic conditions...These drugs represent advancements in medical treatments, offering solutions for diabetes management and obesity (GLP-1 agonists), cost-effective alternatives to biologics (biosimilars) and cutting-edge therapies targeting genetic and cellular aspects of diseases."
3. Increasing Volume of Large Claimants & Chronic Conditions: "Many employers saw an increase in the volume of large claimants in 2023 – not necessarily catastrophic, but those that would not reach typical stop loss thresholds...The increased volume of large claimants has been primarily driven by unit cost, such as elevated costs for specialty drugs and medical procedures."
https://lnkd.in/gngrGXhA
Brown & Brown’s 2024 Employee Benefits Market Trends report is now available! Our Market Trends quickly connects you to key topics and notable updates in the employee benefits marketplace. https://lnkd.in/gASp32Pd
2024 Employee Benefits Market Trends
bbrown.com